| 臺大學術典藏 |
2022-03-09T03:12:25Z |
Predilection of contralateral upper lung metastasis in upper lobe lung adenocarcinoma patients
|
Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Su K.-Y.; Chen H.-Y.; Chang C.-S.; Chen J.J.W.; Yu S.-L.; HUEI-WEN CHEN; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2022-03-09T03:12:22Z |
High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment na?ve advanced EGFR-mutant lung adenocarcinoma patients
|
Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; Su K.-Y.; Chen J.J.W.; HUEI-WEN CHEN; Yu S.-L.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2022-03-09T03:12:22Z |
The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma
|
Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Hsu C.-H.; Su K.-Y.; Chen J.J.W.; HUEI-WEN CHEN; Yu S.-L.; Yang T.-Y.; Chang G.-C. |
| 臺大學術典藏 |
2022-03-04T06:53:44Z |
The role of IL-8 in the SDF-1α/CXCR4-induced angiogenesis of laryngeal and hypopharyngeal squamous cell carcinoma
|
Li K.-C.; Huang Y.-H.; Ho C.-Y.; Chu C.-Y.; Cha S.-T.; Tsai H.-H.; Ko J.-Y.; Chang C.-C.; CHING-TING TAN |
| 臺大學術典藏 |
2022-02-23T02:19:42Z |
Induction of microRNA-10a using retinoic acid receptor-α and retinoid x receptor-α agonists inhibits atherosclerotic lesion formation
|
Lee D.-Y.; Yang T.-L.; Huang Y.-H.; Lee C.-I.; Chen L.-J.; Shih Y.-T.; Wei S.-Y.; Wang W.-L.; CHIH-CHENG WU; Chiu J.-J. |
| 臺大學術典藏 |
2022-02-23T02:12:40Z |
The role of transcatheter arterial embolization in patients with resectable hepatocellular carcinoma: A nation-wide, multicenter study
|
Huang Y.-H.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Wang S.-Y.; Lee P.-C.; Lee H.-S.; Lin P.-W.; Huang G.-T.; Sheu J.-C.; Tsai H.-M.; Chau G.-Y.; Chiang J.-H.; Liu W.-Y.; Lee S.-D.; Wu J.-W. |
| 臺大學術典藏 |
2022-02-23T02:12:40Z |
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery
|
Huang Y.-H.; CHIEN-HUNG CHEN; Chang T.-T.; Chen S.-C.; Wang S.-Y.; Lee H.-S.; Lin P.-W.; Huang G.-T.; Sheu J.-C.; Tsai H.-M.; Lee P.-C.; Chau G.-Y.; Lui W.-Y.; Lee S.-D.; Wu J.-C. |
| 臺大學術典藏 |
2022-02-23T02:12:39Z |
Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter
|
Huang Y.-H.; Wu J.-C.; Chen S.-C.; CHIEN-HUNG CHEN; Chiang J.-H.; Huo T.-I.; Lee P.-C.; Chang F.-Y.; Lee S.-D. |
| 臺大學術典藏 |
2022-02-23T02:12:39Z |
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area
|
Huang Y.-H.; Wu J.-C.; CHIEN-HUNG CHEN; Chang T.-T.; Lee P.-C.; Chau G.-Y.; Lui W.-Y.; Chang F.-Y.; Lee S.-D. |
| 臺大學術典藏 |
2022-02-23T02:12:24Z |
Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Lu S.-N.; Wang J.-H.; Su C.-W.; Wang T.-E.; Dai C.-Y.; CHIEN-HUNG CHEN; Chen R.-C.; Yang S.-S.; Hung C.-F.; Huang S.-F.; Liao L.-Y.; Huo T.-I.; Wu C.-C.; Lee P.-H.; Ting C.-T.; Lee W.-C.; Chau G.-Y.; Wang C.-C.; Lee K.-T.; Huang Y.-H.; Ho M.-C.; Lin S.-M.; Huang G.-T.; Chen K.-Y.; Lin X.-Z.; Hwang J.-I.; Chiou Y.-Y.; Wang C.-K.; Hu J.-T.; Chen S.-C.; Liang P.-C.; Lee R.-C.; Wu D.-K.; Lin C.-Y.; Lin C.-C.; Cheng A.-L.; Hsu C.; Chao Y.; Chen L.-T.; Wang P.-M.; Wang P.-M.; Hong J.-H.; Hsu H.-C.; Chen S.-W.; Leung S.W.; Cheng J.C.-H.; Wu J.-C.; Wu C.-Y.; Hsu Y.-C.; Hsu C.-W.; Ni Y.-H.; Lin C.-L.; Local ablation group, Surveillance group, Diagnosis group, Staging group, Surgery group, TACE/TARE/HAI group, Target therapy/systemic therapy group, Radiotherapy group, Prevention group, Drafting group |
